Arqit Quantum looks overvalued at 397.6x FY26 EV/Sales amid dilution, cash burn, and execution risks. Read why ARQQ stock is ...
Plasma cell-free RNA (cfRNA) is a promising source of non-invasive biomarkers, but its clinical translation is hindered by technical challenges and a lack of protocol standardization, which ...
Operating matter-wave interferometers as quantum detectors for fundamental physics or inertial sensors with unprecedented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results